Abstract
Abstract
Background
This study delves into the critical issues related to delay in diagnosis and associated factors surrounding cancer care in the elderly, particularly focusing on the Indian demographic. The research approved by an institutional ethics committee, involved analyzing patient records and conducting interviews at a hospital to understand the time taken for cancer diagnosis and initiation of treatment in older patients.
Method and Result
A total of 80 study participants with histologically confirmed cancers were included in this study. The majority of patients belonged to the 65–75 years age group (n = 62, 77.5%). Only 18 (22.5%) were in the age group of 76–85 years. Of the total patients, the disease was confined to the primary site in 45 (56.2%) and it had nodal spread or metastasized in 35 (43.7%) at the time of first diagnosis. After treatment completion, during the first month of follow-up, 2 cases of gastrointestinal cancer died, and 1 case of genitourinary and other cancers died. During the second month of follow-up, 3 cases of gastrointestinal cancer died, 4 cases of genitourinary cancer died, and 2 cases of other cancers died. During the sixth month of follow-up, 2 cases of head & neck and genitourinary cancer died, and 5 cases of gastrointestinal and other cancers died.
Conclusion
The study highlights the need for increased awareness of delays in diagnosis and treatment of cancer in the geriatric age group and government intervention in the form of setting up geriatric cancer units to provide affordable cancer treatment aiming to improve the quality of life survival rates in this vulnerable population.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, Bowman KF, Miller RH (2006) Cancer in the elderly. Trans Am Clin Climatol Assoc. 117:147–55. discussion 155-6. PMID: 18528470; PMCID: PMC1500929
2. Owusu C, Berger NA (2014) Comprehensive geriatric assessment in the older cancer patient: coming of age in clinical cancer care. Clin Pract (Lond) 11(6):749–762. https://doi.org/10.2217/cpr.14.72. PMID:25642321;PMCID:PMC4308946
3. Laconi E, Marongiu F, DeGregori J (2020) Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br J Cancer 122:943–952. https://doi.org/10.1038/s41416-019-0721-1
4. Abdel-Razeq H, Abu Rous F, Abuhijla F, Abdel-Razeq N, Edaily S (2022) Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects. Clin Interv Aging 28(17):1445–1460. https://doi.org/10.2147/CIA.S365497. PMID:36199974;PMCID:PMC9527811
5. Nguyen NP, Baumert BG, Oboite E, Motta M, Appalanaido GK, Arenas M, Lara PC, Bonet M, Zamagni A, Vuong T, Popescu T, Karlsson U, Trigo L, Sun Myint A, Thariat J, Vinh-Hung V (2021) Immunotherapy and Radiotherapy for Older Cancer Patients during the COVID-19 Era: Proposed Paradigm by the International Geriatric Radiotherapy Group. Gerontology. 67(4):379–385. https://doi.org/10.1159/000514451. Epub 2021 Mar 30. PMID: 33784693; PMCID: PMC8089416